Medical technology company Polarcool intends to apply for delisting from Spotlight Stock Market, subject to approval at an extraordinary general meeting on August 4. The company is aiming for a listing in the U.S. within 18-24 months and believes that a period as an unlisted company will improve the chances of raising capital and expanding in North America.- Polarcool is entering an exciting phase where our opportunities in North America are becoming increasingly clear. The board believes that a future listing in the U.S. could give us access to a larger capital market, improved financing opportunities and increased visibility in a market where we see significant commercial potential, says CEO Erik Andersson in a comment.The application for delisting is expected to be submitted on October 5, with the provisional last trading day later that same month.